Difficulty: Medium
Average Score: 89%
Practice
Select the correct statement about salmeterol.
Correct answer
A
Rationale
Rationale:
The correct statement about salmeterol is option A) It is a long-acting selective ╬▓Ôéü agonist bronchodilator. Salmeterol is a long-acting beta-agonist that acts on ╬▓Ôéé receptors in the lungs, leading to bronchodilation by relaxing the smooth muscles in the airways. This results in improved airflow and helps in managing conditions like asthma and chronic obstructive pulmonary disease (COPD).
Option B) is incorrect because salmeterol is not an anti-inflammatory medication. It does not possess properties to reduce inflammation in the airways like corticosteroids do.
Option C) is incorrect as salmeterol is not a beta-blocker. Beta-blockers are contraindicated in asthmatics as they can worsen bronchoconstriction.
Option D) is also incorrect because salmeterol is not an antihistaminic with mast cell stabilizing properties. It does not target histamine receptors or stabilize mast cells to prevent allergic reactions.
Understanding the pharmacological properties of medications used to treat respiratory conditions like salmeterol is crucial for healthcare professionals to make informed decisions in managing patients with these conditions effectively. It is essential to differentiate between different classes of drugs and their mechanisms of action to provide safe and appropriate care for patients with respiratory issues.
The correct statement about salmeterol is option A) It is a long-acting selective ╬▓Ôéü agonist bronchodilator. Salmeterol is a long-acting beta-agonist that acts on ╬▓Ôéé receptors in the lungs, leading to bronchodilation by relaxing the smooth muscles in the airways. This results in improved airflow and helps in managing conditions like asthma and chronic obstructive pulmonary disease (COPD).
Option B) is incorrect because salmeterol is not an anti-inflammatory medication. It does not possess properties to reduce inflammation in the airways like corticosteroids do.
Option C) is incorrect as salmeterol is not a beta-blocker. Beta-blockers are contraindicated in asthmatics as they can worsen bronchoconstriction.
Option D) is also incorrect because salmeterol is not an antihistaminic with mast cell stabilizing properties. It does not target histamine receptors or stabilize mast cells to prevent allergic reactions.
Understanding the pharmacological properties of medications used to treat respiratory conditions like salmeterol is crucial for healthcare professionals to make informed decisions in managing patients with these conditions effectively. It is essential to differentiate between different classes of drugs and their mechanisms of action to provide safe and appropriate care for patients with respiratory issues.